Press Releases

Notice of Extraordinary Shareholders’ Meeting on 7th September 2020 Regarding Proposed Warrant Plans
7 August 2020
EN FR

Information on the Total Number of Voting Rights (Denominator) Following the Completion of the LDA Capital Increase
5 August 2020
EN FR

Mithra announces shelf life extension for Myring™ to 36 months
4 August 2020
EN FR

Mithra Announces Commercial Launch of Tibelia® in Canada
30 July 2020
EN FR

Mithra’s EGM Approves Warrant Plan for LDA Capital
23 July 2020
EN FR

Mithra Signs License and Supply Agreement for Commercialization of Myring™ in Mexico
14 July 2020
EN FR

Publication of a Transparency Notification Received from Alychlo NV
10 July 2020
EN FR

Publication of a Transparency Notification Received from Ogesip Invest SA
9 July 2020
EN FR

Mithra Signs LSA for Commercialization of Myring™ in France, Poland and United Kingdom
6 July 2020
EN FR

Mithra Announces FDA Filing Acceptance of New Drug Application for Estelle® in the US
24 June 2020
EN FR

Information on the Total Number of Voting Rights (Denominator)
23 June 2020
EN FR

Notice of Extraordinary Shareholders’ Meeting on 22th July 2020 Regarding Proposed Warrant Plans
19 June 2020
EN FR